BRIEF published on 04/13/2026 at 17:07, 2 months 8 days ago Marinomed Biotech AG finalise avec succès son augmentation de capital Augmentation De Capital Confiance Des Investisseurs Bourse De Vienne Actions Émises Biotechnologie Marinomed
PRESS RELEASE published on 04/13/2026 at 17:02, 2 months 8 days ago Marinomed secures financing through successful capital increase Marinomed Biotech AG successfully completes capital increase, securing EUR 2.23 million in gross proceeds. Financing to support company's milestones and flagship products marketing Financing Capital Increase Marinomed Biotech AG Rights Offering Marinosolv Technology
BRIEF published on 03/23/2026 at 17:49, 2 months 29 days ago Marinomed Biotech AG : Augmentation de capital et perspectives financières pour 2025 Augmentation De Capital Marinomed Résultats 2025 Déficit De Liquidités Opportunité Pour Les Actionnaires
BRIEF published on 03/23/2026 at 17:49, 2 months 29 days ago Marinomed Biotech AG: Capital Increase and 2025 Financial Outlook Capital Increase Marinomed 2025 Results Liquidity Gap Shareholder Opportunity
PRESS RELEASE published on 03/23/2026 at 17:44, 2 months 29 days ago Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research issues a Buy recommendation with a target price of EUR 50 for Marinomed Biotech AG due to a capital increase and delayed Carragelose earn-out revenues First Berlin Equity Research Buy Recommendation Capital Increase Marinomed Biotech AG Carragelose Earn-out
BRIEF published on 03/19/2026 at 16:52, 3 months 2 days ago Marinomed Biotech Initiates Capital Increase with Subscription Rights Capital Increase Subscription Rights Marinomed Biotech Fiscal Outlook Liquidity Gap
BRIEF published on 03/19/2026 at 16:52, 3 months 2 days ago Marinomed Biotech lance une augmentation de capital par souscription de droits Augmentation De Capital Biotechnologie Marinomed Droits D'abonnement Perspectives Budgétaires Déficit De Liquidités
PRESS RELEASE published on 03/19/2026 at 16:47, 3 months 2 days ago Marinomed Biotech Announces Capital increase with subscription rights Marinomed Biotech plans a capital increase with subscription rights supported by an institutional investor to meet short-term capital needs. Preliminary financial figures for 2025 show revenue growth Capital Increase Financial Figures Subscription Rights Marinomed Biotech Institutional Investor
BRIEF published on 03/19/2026 at 16:19, 3 months 2 days ago Marinomed Biotech AG Initiates Cash Capital Increase Capital Increase Subscription Rights Marinomed Biotech Carragelose Transfer Short-term Liquidity
BRIEF published on 03/19/2026 at 16:19, 3 months 2 days ago Marinomed Biotech AG lance une augmentation de capital. Augmentation De Capital Biotechnologie Marinomed Droits D'abonnement Transfert De Perte De Transport Liquidités À Court Terme
Published on 06/20/2026 at 01:00, 2 days 7 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 8 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 4 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 7 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 08:37, 4 minutes ago EQS-Adhoc: OHB SE resolves on up to EUR 510.7 million capital increase with subscription rights at EUR 300 per new share and upfront private placement along with Orchid Lux Hold-Co S.à r.l.
Published on 06/22/2026 at 08:35, 6 minutes ago As K-Beauty Heats Up Amazon DE Prime Day, COSRX Leads with Up to 52% Off Bestsellers
Published on 06/22/2026 at 08:35, 6 minutes ago Brook Auto Catch Light Introduces New Fashion White Edition
Published on 06/22/2026 at 08:00, 41 minutes ago Coinsilium Group Limited: ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 06/22/2026 at 08:30, 11 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 11 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 13 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 13 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
